Malignant Pleural Mesothelioma (MPM)

Oncology·MeSH: Triple Negative Breast Neoplasms

Prevalence

1.0 / 100K

Incidence

0.9 / 100K/yr

0 drugs in development·0 companies·1 clinical trial

Frequently asked questions

How many clinical trials target Malignant Pleural Mesothelioma (MPM)?

There are 1 clinical trial targeting Malignant Pleural Mesothelioma (MPM) tracked by BioSniper.

What is the prevalence of Malignant Pleural Mesothelioma (MPM)?

The estimated prevalence of Malignant Pleural Mesothelioma (MPM) is approximately 1.0 per 100,000 population.

Deep-dive into Malignant Pleural Mesothelioma (MPM)

Full trial data, competitive analysis, and AI-powered pipeline tracking.

Start Free Analysis
    Malignant Pleural Mesothelioma (MPM) — Drugs in Development & Clinical Trials | BioSniper